CoChat

Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities

Dhaliwal, Arash K., Bahji, Anees, Danilewitz, Marlon · 2022 · Canadian Journal of Addiction

The DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.

Abstract

Smoking and tobacco use disorder (TUD) is highly prevalent among individuals with serious and persistent mental illness, particularly those with schizophrenia spectrum disorders. In this clinical case column, we highlight an encounter involving a successful initiation of bupropion for smoking cessation in an individual with schizophrenia. We also review the relevant literature around the epidemiology of TUD among people with schizophrenia, highlight the increased complications and mortality secondary to TUD, and discuss relevant strategies for clinicians to support individuals with serious and persistent mental illness aiming to reduce or stop their tobacco consumption. Le tabagisme et le trouble de l’usage du tabac (TUT) sont très répandus chez les personnes souffrant de maladies mentales graves et persistantes (MMGP), en particulier celles atteintes de troubles du spectre de la schizophrénie. Dans cette chronique de cas cliniques, nous mettons en évidence une rencontre impliquant une initiation réussie du bupropion pour le sevrage tabagique chez une personne atteinte de schizophrénie. Nous passons également en revue la littérature pertinente concernant l'épidémiologie du TUT chez les personnes atteintes de schizophrénie, soulignons l’augmentation des complications et de la mortalité secondaires au TUT, et discutons des stratégies pertinentes pour les cliniciens afin de soutenir les personnes atteintes de MMGP visant à réduire ou à arrêter leur consommation de tabac.

Overview

Integrity signals

Registry

Crossref · 10.1097/cxa.0000000000000164

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 6 references

Metadata

Authors
Dhaliwal, A. K., Bahji, A., & Danilewitz, M.
Affiliations
  • Western University (CA)
  • University of Calgary (CA)
  • University of Toronto (CA)
Venue
Canadian Journal of Addiction
Published
2022-12
Volume
13
Issue
4
Pages
53-55
ISSN
  • 2368-4720 (ISSN-L)
  • 2368-4739
OpenAlex
W4385820720
Cited by
1
References
7
Citations by year
2024: 1
FWCI
0.16
Type
journal article
Language
en
Open access
closed
Locations
The Canadian Journal of Addiction (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
tobacco use disorder, schizophrenia, smoking cessation, bupropion, comorbidities, serious and persistent mental illness, smoking-related mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities. https://app.cochat.ai/papers/10.1097/cxa.0000000000000164
The paper
Dhaliwal, A. K., Bahji, A., & Danilewitz, M. (2022). Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities. Canadian Journal of Addiction. https://doi.org/10.1097/cxa.0000000000000164

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.